Remove Containment Remove Production Remove Research
article thumbnail

World Psoriasis Day 2024: New Treatments and Research Trends

XTalks

Trends in Psoriasis Research: Biologics, Biosimilars and New Therapies Recent innovations in biologics and biosimilars have transformed psoriasis care. Meanwhile, Innovent Biologics recently saw its New Drug Application (NDA) for picankibart, an IL-23p19 inhibitor, accepted by the Chinese National Medical Products Administration (NMPA).

Research 105
article thumbnail

Ethnopharmacology: traditional medicine and modern drug discovery

Pharmaceutical Technology

As healthcare confronts challenges such as antimicrobial resistance and the spread of previously geographically constrained diseases as a result of climate change, research into natural products used in traditional medicine, referred to as ‘ethnopharmacology’, could help in finding new, clinically effective drugs.

Medicine 262
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Children’s products labeled water- or stain-resistant may contain PFAS, study says

Scienmag

Seems like kids are always getting into something, so products marketed toward them often claim to repel liquids. Some items contain potentially harmful per- and polyfluoroalkyl substances (PFAS) to accomplish this feat, but companies aren’t required to disclose these “forever chemicals” on labels.

article thumbnail

Key Considerations for Generic Drug Stability Testing

Drug Patent Watch

Behind the scenes, generic drug manufacturers are working tirelessly to ensure that their products are safe, effective, and identical to their branded counterparts. It helps them to identify potential issues early on, make adjustments as needed, and ultimately bring a high-quality product to market.

article thumbnail

Researchers identify new marker linked to malfunctioning glymphatic system

Medical Xpress

A new study led by UB researchers shows that wasteosomes—structures that act as containers for brain waste products—indicate a malfunction of the glymphatic system, a recently discovered system that is an important brain-cleaning mechanism.

article thumbnail

Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (containing benzyl alcohol), Due To The Potential Presence of Visible Particulates

Pfizer

Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (containing benzyl alcohol), Due To The Potential Presence of Visible Particulates. Propofol Injectable Emulsion is a terminally sterilized (TS) product. Pfizer has notified direct consignees by letter to arrange for return of any recalled product.

article thumbnail

FDA Designations for Rare Disease Products, Part 2: Orphan Drug Designation

Camargo

The Camargo Blog is publishing a four-part blog series highlighting those designation programs available specifically for products with rare disease indications: Orphan Drug Designation (ODD), Rare Pediatric Disease Designation (RPDD), and Humanitarian Use Device (HUD) designation. Definition of a Rare Disease or Condition.